C

ChromaDex Corp
D

CDXC

7.60000
USD
0.16
(2.15%)
مغلق
حجم التداول
33,832
الربح لكل سهم
0
العائد الربحي
-
P/E
380
حجم السوق
580,512,829
أصول ذات صلة
    B
    BGI
    0.02000
    (1.09%)
    1.85000 USD
    J
    JAGX
    -0.08040
    (-7.73%)
    0.95960 USD
    L
    LYRA
    -0.01160
    (-6.38%)
    0.17010 USD
    S
    SNDL
    0.00500
    (0.26%)
    1.95500 USD
    V
    VBIV
    0
    (0%)
    0.000000 USD
    V
    VVOS
    -0.30000
    (-9.58%)
    2.83000 USD
    المزيد
الأخبار

العنوان: ChromaDex Corp

القطاع: Consumer Defensive
الصناعة: Packaged Foods
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.